Interventional Radiology Envita recently appointed a Medical Director for Envita Interventional Radiology, signaling expansion into IR services. This creates opportunities to offer imaging equipment, contrast media, radiation safety gear, and service contracts, plus workflow optimization tools that connect IR with precision oncology programs like GTFC and CIPI. Propose partnerships with AI assisted imaging analytics and interoperable data workflows to improve targeting and patient outcomes.

Data Driven Envita emphasizes genetic, epigenetic, and immune profiling to tailor treatments, indicating demand for genomic sequencing partnerships, lab services, and bioinformatics. There is potential to sell data analytics platforms and secure data integration with their existing tech stack and EHRs, plus benchmarking dashboards that demonstrate ROI and outcomes to payers.

Integrative Therapies The center blends conventional medicine with research based natural therapies, presenting opportunities to partner on nutraceuticals and clinically validated supplements, as well as wellness programs. Consider clinical trial collaborations and compliant supply chains for natural products, with training modules for clinicians and care teams.

Lyme Cancer Synergy Envita's work on chronic Lyme disease and advanced cancer care opens doors for infectious disease and immunology collaborations, including diagnostic test partnerships and immunotherapy services that align with their holistic approach. Opportunities exist in joint research, study enrollment, and cross referrals to expand patient reach and outcomes.

Patient Access With focus on transparency in care and costs, there is demand for patient financing options, price transparency tools, and telemedicine or patient portal enhancements. Offer cost estimation platforms, insurance verification integrations, and blended payment solutions to improve conversion and patient satisfaction.